WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in SERA — Sera Prognostics, Inc.
CIK 1632972
PLYMOUTH, MN
Position in SERA
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$19,117
-$2,315 QoQ
Shares Held
10,504
-0.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 46 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SERA Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $291,122,982 across 58 Medical Devices names. SERA ranks #56 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,164,059 | $105,626,713 | |
| 2 | MDT |
Medtronic plc
|
921,461 | $72,085,894 | |
| 3 | SYK |
Stryker Corp
|
135,035 | $42,514,419 | |
| 4 | BSX |
Boston Scientific Corp
|
249,780 | $10,660,610 | |
| 5 | EW |
Edwards Lifesciences Corp
|
89,705 | $8,114,714 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
74,825 | $6,441,684 | |
| 7 | TXG |
10x Genomics, Inc.
|
159,113 | $6,100,392 | |
| 8 | STE |
STERIS plc
|
28,195 | $5,937,021 |
All Filings in SERA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,117 | 10,504 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $21,432 | 10,558 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $31,385 | 10,639 | Shares | Sole | 2026-01-08 | |
| 2025-06-30 | $274,659 | 99,155 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $363,451 | 98,764 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,284,858 | 157,845 | Shares | Sole | 2025-03-17 | |
| No filing history on record for this holder in this stock. | ||||||